1620 Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
1620 Investment Advisors, Inc.
- $142 Million
- Q3 2025
A detailed history of 1620 Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 18,310 shares of BMY stock, worth $854,161. This represents 0.58% of its overall portfolio holdings.
Number of Shares
18,310
Previous 14,109
29.78%
Holding current value
$854,161
Previous $653,000
26.34%
% of portfolio
0.58%
Previous 0.49%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.56BCall Options Held
24.3MPut Options Held
25.7M-
Vanguard Group Inc Valley Forge, PA196MShares$9.14 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.4 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.51 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.02 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.41 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.2B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...